Skip to main content

Table 1 Baseline characteristics of 40 HIV-infected patients

From: Treatment outcomes and plasma level of ritonavir-boosted lopinavir monotherapy among HIV-infected patients who had NRTI and NNRTI failure

Baseline characteristics

Number (%), n = 40

Demographics

 

Age, mean ± SD, years

37.1 ± 8.0

Male gender, number (%)

28 (70)

Body weight, mean ± SD, Kilograms

57 ± 21

Body mass index, mean ± SD

22.7 ± 4.6

Duration of previous ART, median (IQR), years

2.1 (0.8-3.2)

Laboratory parameters

 

CD4 cell counts at virological failure, mean ± SD, cells/mm3

144 ± 124

Percentage of CD4 cell at virological failure, mean ± SD, %

7.7 ± 5.1

Plasma HIV-1 RNA at virological failure, median (IQR), copies/mL

55,800

(9,670-100,000)

   Log, copies/mL

4.8 (4.0-5.0)

Total cholesterol, mean ± SD, mg/dL

165 ± 42

HDL choleterol, mean ± SD, mg/dL

41 ± 30

Triglyceride, mean ± SD, mg/dL

172 ± 117

Total cholesterol:HDL ratio ≥6.5, number (%)

2 (5)

Fasting blood sugar, mean ± SD, mg%

100 ± 27

Patients with ≥3 TAMs, number (%)

13 (32.5%)

Patients with Q151M, number (%)

7 (18%)